Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13576365 | 0.87 | — | — | |
| Hydrochloric Acid SCHEMBL30516243 | 0.84 | — | — | |
| SCHEMBL12457880 | 0.82 | — | — | |
| SCHEMBL18911774 | 0.82 | — | — | |
| SCHEMBL12457631 | 0.82 | — | — | |
| Hydrochloric Acid SCHEMBL5531798 | 0.80 | — | — | |
| SCHEMBL7888522 | 0.78 | — | — | |
| SCHEMBL12457874 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL19747200 | 0.76 | USP2 (0.34) | DRD4OPRM1 | |
| SCHEMBL22253844 | 0.76 | OPRM1 (0.32) | DRD4OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 78 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220073735-A1 | LIQUIDS | Borchers Catalyst (UK) Limited (GB) | 2022-03-10 | — | — | US | claimed |
| EP-3818101-A1 | LIQUIDS | Borchers Catalyst (UK) Limited (GB) | 2021-05-12 | — | — | EP | claimed |
| CN-112739758-A | Liquid, method for producing the same and use thereof | 博奇斯催化剂(英国)有限公司 | 2021-04-30 | — | — | CN | claimed |
| EP-3307941-B1 | OXIDATIVE METHOD | CATEXEL TECH LIMITED (GB) | 2021-03-24 | — | — | EP | claimed |
| US-10882745-B2 | Oxidative method | CATEXEL TECHNOLOGIES LIMITED (GB) | 2021-01-05 | — | — | US | claimed |
| CN-107709533-B | Oxidation process | 卡特克塞尔科技有限公司 | 2020-09-18 | — | — | CN | claimed |
| WO-2020008203-A1 | LIQUIDS | CATEXEL LIMITED (GB) | 2020-01-09 | — | — | WO | claimed |
| US-10457831-B2 | Oxidatively curable coating composition | CATEXEL LIMITED (GB) | 2019-10-29 | — | — | US | claimed |
| US-20180186634-A1 | OXIDATIVE METHOD | CATEXEL B.V. (NL) | 2018-07-05 | — | — | US | claimed |
| EP-3307941-A1 | OXIDATIVE METHOD | Catexel Technologies Limited (GB) | 2018-04-18 | — | — | EP | claimed |
| EP-2954014-B1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL LTD (GB) | 2017-11-08 | — | — | EP | claimed |
| WO-2016198891-A1 | OXIDATIVE METHOD | CHEMSENTI LIMITED (GB) | 2016-12-15 | — | — | WO | claimed |
| EP-2954014-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | Catexel Limited (GB) | 2015-12-16 | — | — | EP | claimed |
| US-20150337163-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL LIMITED (GB) | 2015-11-26 | — | — | US | claimed |
| WO-2014122434-A1 | OXIDATIVELY CURABLE COATING COMPOSITION | CATEXEL LIMITED (GB) | 2014-08-14 | — | — | WO | claimed |
| EP-1280794-B1 | DIAZACYCLOALKANE DERIVATIVES AS BLEACH CATALYST AND COMPOSITION AND METHOD FOR BLEACHING A SUBSTRATE | UNILEVER PLC (GB) | 2006-07-05 | — | — | EP | claimed |
| US-20020049148-A1 | Bleach catalyst and composition and method for bleaching a substrate | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-04-25 | — | — | US | claimed |
| EP-4077464-B1 | FREE RADICAL POLYMERIZABLE ADHESION-PROMOTING INTERLAYER COMPOSITIONS AND METHODS OF USE | PRC DESOTO INT INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-6537959-B2 | Diazacycloalkanes, i.e., 1,4,6-trimethyl-6-(n-(pyridin-2-ylmethyl)-N-methylamino)-1,4 -diazacycloheptane; ligands in manganese, iron and cobalt transition metal complexes. | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2003-03-25 | — | — | US | disclosed |
| US-20020049148-A1 | Bleach catalyst and composition and method for bleaching a substrate | UNILEVER HOME & PERSONAL CARE USA, DIVISION OF CONOPCO, INC. | 2002-04-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10882745-B2 | Oxidative method | CAT, LPO, GPX4 | DRD4 1652/4885OPRM1 2812/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.